Contraception

What’s new in contraception for 2022?

May 08, 2022

Data still hazy for immediate postpartum hormonal contraception and postpartum depression

May 06, 2022

A recent study presented at the 2022 American College of Obstetricians & Gynecologists' Annual Clinical & Scientific Meeting found that there was neither a decreased nor increased risk for postpartum depression in patients who received hormonal contraception due to insufficient evidence.

Report: Women abandoning contraception due to misinformation

May 02, 2022

Elizabeth Ruzzo, PhD, discusses the findings of a report published by the UNFPA, which found women were abandoning effective methods of contraception due to misinformation.

Tips from PAS 2022 on having "the talk" with teen patients

April 25, 2022

Helen C. Wang, MD, shares key takeaways from the session she co-presented at PAS 2022.

Trending on TikTok: IUD insertion: Does it hurt?

March 15, 2022

TikTok user @midwifemama sparked a conversation about IUD insertion.

Increased access to immediate postpartum LARC improves birth outcomes

February 28, 2022

A cohort study in JAMA Pediatrics indicates that policies that increase access to immediate postpartum long-acting reversible contraception (LARC) improve birth outcomes.

Caring for women who are or have been incarcerated: contraception, sexual health, and trauma-informed care

February 28, 2022

In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.

Contraception selection, efficacy, and risks

February 09, 2022

Contraceptive effectiveness is determined by several factors, including drug or device efficacy, individual fecundability, coital frequency, and user adherence and continuation.

Combined oral contraceptives for patients with rheumatoid arthritis

February 08, 2022

While the use of combined oral contraceptives (COCs) among patients with rheumatoid and autoimmune disorders have focused on safety, a narrative review in the Journal of Obstetrics and Gynaecology Research highlighted the efficacy and benefits of these contraceptives in females with rheumatoid arthritis (RA).

Efficacy of combined oral contraceptives for treating depression in premenstrual women

February 07, 2022

Combined oral contraceptives were found to be moderately more efficacious than placebo for treating overall premenstrual symptomatology in women with premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD).